Literature DB >> 6670062

Preschool vision screening for amblyopia and strabismus. Programs, methods, guidelines, 1983.

M I Ehrlich, R D Reinecke, K Simons.   

Abstract

Amblyopia and strabismus, which afflict at least 5% of children, require treatment early in life for best visual results. At present, many such children are treated late or not at all. Mass screening at preschool age, and perhaps ultimately of infants, appears the only viable solution to this problem. To ascertain the present status of preschool screening in the United States, on-site visits, mail questionnaires and telephone interviews were used to study existing preschool vision screening programs at the federal, state and private organization levels. We estimate that, at most, 21% of preschool children receive any form of vision screening. Only two states, Michigan and Minnesota, have legislated requirements for such screening. Several organizations have attempted to establish screening guidelines, with suggestions of specific test and referral criteria. These guidelines are reviewed. The guidelines are of particular interest because screening programs following them typically indicate far lower prevalence rates than most studies indicate actually exist, suggesting that the guidelines result in underreferrals. In order to assess this matter, vision screening methods appropriate for preschoolers or infants, based on current evidence, are reviewed. Stereoscopic testing, utilizing a random dot stereogram format, appears the best instrument available for amblyopia and strabismus screening, but large scale comparative studies of the different test methods are needed to arrive at a final determination. Suggestions are made for the physician interested in initiating preschool vision screening programs.

Entities:  

Mesh:

Year:  1983        PMID: 6670062     DOI: 10.1016/0039-6257(83)90092-9

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  21 in total

1.  Prevalence of eye diseases in primary school children in a rural area of Tanzania.

Authors:  S H Wedner; D A Ross; R Balira; L Kaji; A Foster
Journal:  Br J Ophthalmol       Date:  2000-11       Impact factor: 4.638

2.  Comparison of the Retinomax and Palm-AR Auto-Refractors: a pilot study.

Authors:  Elise Ciner; Ashanti Carter; Gui-Shuang Ying; Maureen Maguire; Marjean Taylor Kulp
Journal:  Optom Vis Sci       Date:  2011-07       Impact factor: 1.973

3.  The Seoul Metropolitan Preschool Vision Screening Programme: results from South Korea.

Authors:  H T Lim; Y S Yu; S-H Park; H Ahn; S Kim; M Lee; J-Y Jeong; K H Shin; B S Koo
Journal:  Br J Ophthalmol       Date:  2004-07       Impact factor: 4.638

4.  The use of choline in association with the Bangerter filters for the treatment of amblyopia.

Authors:  Lelio Sabetti; Francesco Masedu; Chiara Tresca; Federica Bianchi; Marco Valenti
Journal:  Int J Ophthalmol       Date:  2017-11-18       Impact factor: 1.779

5.  Screening for visual defects in pre-school children.

Authors:  K Simons
Journal:  Br J Ophthalmol       Date:  1987-04       Impact factor: 4.638

6.  A double dissociation of the acuity and crowding limits to letter identification, and the promise of improved visual screening.

Authors:  Shuang Song; Dennis M Levi; Denis G Pelli
Journal:  J Vis       Date:  2014-05-05       Impact factor: 2.240

7.  Vision screening programs in children.

Authors:  K F Damji
Journal:  Can Fam Physician       Date:  1988-05       Impact factor: 3.275

8.  Validation of dynamic random dot stereotests in pediatric vision screening.

Authors:  Anna Budai; András Czigler; Eszter Mikó-Baráth; Vanda A Nemes; Gábor Horváth; Ágota Pusztai; David P Piñero; Gábor Jandó
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-10-03       Impact factor: 3.117

Review 9.  [The detection of vision disorders in children].

Authors:  J Grégoire
Journal:  Can Fam Physician       Date:  1993-06       Impact factor: 3.275

10.  A new computer program for mass screening of visual defects in preschool children.

Authors:  D Briscoe; T Lifshitz; M Grotman; A Kushelevsky; H Vardi; S Weizman; B Biedner
Journal:  Br J Ophthalmol       Date:  1998-04       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.